- Home
- SONN vs NUWE Comparison
SONN vs NUWE Comparison
Compare SONN & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- NUWE
- Stock Information
- Founded
- SONN N/A
- NUWE 1999
- Country
- SONN United States
- NUWE United States
- Employees
- SONN N/A
- NUWE N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SONN Health Care
- NUWE Health Care
- Exchange
- SONN Nasdaq
- NUWE Nasdaq
- Market Cap
- SONN 3.8M
- NUWE 3.9M
- IPO Year
- SONN N/A
- NUWE N/A
- Fundamental
- Price
- SONN $1.17
- NUWE $0.86
- Analyst Decision
- SONN Strong Buy
- NUWE Strong Buy
- Analyst Count
- SONN 1
- NUWE 1
- Target Price
- SONN $20.00
- NUWE $17.00
- AVG Volume (30 Days)
- SONN 35.4K
- NUWE 47.9K
- Earning Date
- SONN 05-13-2025
- NUWE 05-13-2025
- Dividend Yield
- SONN N/A
- NUWE N/A
- EPS Growth
- SONN N/A
- NUWE N/A
- EPS
- SONN N/A
- NUWE N/A
- Revenue
- SONN $1,000,000.00
- NUWE $8,787,000.00
- Revenue This Year
- SONN $5,376.22
- NUWE $22.96
- Revenue Next Year
- SONN N/A
- NUWE $29.97
- P/E Ratio
- SONN N/A
- NUWE N/A
- Revenue Growth
- SONN 978.39
- NUWE N/A
- 52 Week Low
- SONN $1.08
- NUWE $0.75
- 52 Week High
- SONN $16.00
- NUWE $10.33
- Technical
- Relative Strength Index (RSI)
- SONN 41.48
- NUWE 39.24
- Support Level
- SONN $1.08
- NUWE $0.93
- Resistance Level
- SONN $1.21
- NUWE $0.95
- Average True Range (ATR)
- SONN 0.08
- NUWE 0.06
- MACD
- SONN -0.01
- NUWE -0.01
- Stochastic Oscillator
- SONN 30.00
- NUWE 0.00
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.